Patents by Inventor Sangeeta Chavan

Sangeeta Chavan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for real-time monitoring of physiological biomarkers through nerve signals and uses thereof
    Patent number: 11872371
    Abstract: The present disclosure relates to systems, methods and devices to monitor, diagnose and/or treat diseases or disorders comprising a calibration phase and a real-time diagnostic, treatment or monitoring phase, the calibration phase correlating a plurality of nerve activity measurements from a chronically implanted electrode in a subject with a plurality of concurrent measurements of levels of cytokines and/or glucose in the blood to obtain a functional relationship between blood cytokine and/or glucose levels and vagus nerve activity, and the diagnostic, treatment or monitoring phase analyzing the subject's real-time vagus nerve activity in accordance with the previously obtained functional relationship to initiate a treatment method.
    Type: Grant
    Filed: April 19, 2018
    Date of Patent: January 16, 2024
    Assignee: THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
    Inventors: Theodoros Zanos, Todd Levy, Emily Battinelli, Kevin J. Tracey, Chad E. Bouton, Sangeeta Chavan, Harold Silverman
  • SYSTEMS AND METHODS FOR REAL-TIME MONITORING OF PHYSIOLOGICAL BIOMARKERS THROUGH NERVE SIGNALS AND USES THEREOF
    Publication number: 20200179600
    Abstract: The present disclosure relates to systems, methods and devices to monitor, diagnose and/or treat diseases or disorders comprising a calibration phase and a real-time diagnostic, treatment or monitoring phase, the calibration phase correlating a plurality of nerve activity measurements from a chronically implanted electrode in a subject with a plurality of concurrent measurements of levels of cytokines and/or glucose in the blood to obtain a functional relationship between blood cytokine and/or glucose levels and vagus nerve activity, and the diagnostic, treatment or monitoring phase analyzing the subject's real-time vagus nerve activity in accordance with the previously obtained functional relationship to initiate a treatment method.
    Type: Application
    Filed: April 19, 2018
    Publication date: June 11, 2020
    Applicant: THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
    Inventors: Theodoros Zanos, Todd Levy, Emily Battinelli, Kevin J. Tracey, Chad E. Bouton, Sangeeta Chavan, Harold Silverman
  • HMGB1-BINDING BEADS AND USES THEREOF
    Publication number: 20150335763
    Abstract: Disclosed are therapeutic beads comprising agents, such as nucleic acids, that bind to high mobility group box 1 (HMGB1) and methods of treating subjects with conditions that would benefit from reducing the deleterious effects of HMGB1, such as inflammatory bowel diseases, comprising administering the beads to the gastrointestinal tract of the subjects.
    Type: Application
    Filed: January 9, 2014
    Publication date: November 26, 2015
    Applicant: The Feinstein Institute For Medical Research
    Inventors: Sangeeta Chavan, Jacob Levine, Yehuda Tamari, Kevin J. Tracey, Huan Yang
  • Methods for treatment of inflammatory diseases
    Patent number: 9005615
    Abstract: The present invention provides methods of treating inflammatory diseases in a subject comprising administering to the subject a therapeutically effective amount of an agent that inhibits pigment epithelium-derived factor (PEDF) and methods of screening for agents that inhibit PEDF.
    Type: Grant
    Filed: May 5, 2011
    Date of Patent: April 14, 2015
    Assignee: The Feinstein Institute For Medical Research
    Inventors: Kevin Tracey, Sangeeta Chavan
  • METHODS FOR TREATMENT OF INFLAMMATORY DISEASES
    Publication number: 20130071389
    Abstract: The present invention provides methods of treating inflammatory diseases in a subject comprising administering to the subject a therapeutically effective amount of an agent that inhibits pigment epithelium-derived factor (PEDF) and methods of screening for agents that inhibit PEDF.
    Type: Application
    Filed: May 5, 2011
    Publication date: March 21, 2013
    Applicant: The Feinstein Institute For Medical Research
    Inventors: Kevin Tracey, Sangeeta Chavan